<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jarosz A</submitter><funding>Medical University of Silesia in Katowice</funding><funding>Medical University of Silesia</funding><pagination>3504</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9224593</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(12)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>This study aims to identify genotype variants of the platelet-derived growth factor alpha polypeptide gene (&lt;i>PDGFA&lt;/i>) that can influence the individual response to the treatment with platelet-rich plasma (PRP) in tennis elbow patients.&lt;h4>Methods&lt;/h4>We observed a cohort of 107 patients (132 elbows) with tennis elbow who received treatment with PRP. Patients have been followed-up for two years after PRP injection and the effectiveness of the treatment was measured using universal patient-reported outcome measures (PROMs): visual analog scale (VAS), quick version of disabilities of the arm, shoulder and hand score (QDASH), and patient-rated tennis elbow evaluation (PRTEE). PROMs values, and clinical and platelet parameters were compared between genotype variants of th</pubmed_abstract><journal>Journal of clinical medicine</journal><pubmed_title>What Role Does &lt;i>PDGFA&lt;/i> Gene Polymorphisms Play in Treating Tennis Elbow with PRP? A Prospective Cohort Study.</pubmed_title><pmcid>PMC9224593</pmcid><funding_grant_id>PCN-1-071/K/0/Z</funding_grant_id><funding_grant_id>PCN-1-096/K/1/Z</funding_grant_id><pubmed_authors>Balcerzyk A</pubmed_authors><pubmed_authors>Negru M</pubmed_authors><pubmed_authors>Gorczynska-Kosiorz S</pubmed_authors><pubmed_authors>Garczorz W</pubmed_authors><pubmed_authors>Szyluk K</pubmed_authors><pubmed_authors>Iwanicka J</pubmed_authors><pubmed_authors>Kalita M</pubmed_authors><pubmed_authors>Jarosz A</pubmed_authors><pubmed_authors>Francuz T</pubmed_authors><pubmed_authors>Iwanicki T</pubmed_authors><pubmed_authors>Niemiec P</pubmed_authors><pubmed_authors>Nowak T</pubmed_authors><pubmed_authors>Kania W</pubmed_authors></additional><is_claimable>false</is_claimable><name>What Role Does &lt;i>PDGFA&lt;/i> Gene Polymorphisms Play in Treating Tennis Elbow with PRP? A Prospective Cohort Study.</name><description>&lt;h4>Background&lt;/h4>This study aims to identify genotype variants of the platelet-derived growth factor alpha polypeptide gene (&lt;i>PDGFA&lt;/i>) that can influence the individual response to the treatment with platelet-rich plasma (PRP) in tennis elbow patients.&lt;h4>Methods&lt;/h4>We observed a cohort of 107 patients (132 elbows) with tennis elbow who received treatment with PRP. Patients have been followed-up for two years after PRP injection and the effectiveness of the treatment was measured using universal patient-reported outcome measures (PROMs): visual analog scale (VAS), quick version of disabilities of the arm, shoulder and hand score (QDASH), and patient-rated tennis elbow evaluation (PRTEE). PROMs values, and clinical and platelet parameters were compared between genotype variants of th</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2026-05-07T03:08:10.468Z</modification><creation>2025-02-19T02:58:33.612Z</creation></dates><accession>S-EPMC9224593</accession><cross_references><pubmed>35743573</pubmed><doi>10.3390/jcm11123504</doi></cross_references></HashMap>